Back to search

Article

Risk Assessment and Management of Drug Inventory in Hospitals during COVID-19 Pandemic in Taiwan

2020-06-11

Abstract excerpt

<title>Abstract</title> <p>Background The COVID-19 pandemic has caused the suspension of active pharmaceutical ingredients (APIs) production in China, the source of the global largest medication supply chain, resulting in the potential risks of hospital insufficient drug stocks affecting clinical treatment. If all drug inventory of the hospital increased, the short-term drug shortage risk can be reduced, but the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4a2e965-b749-53f3-9a67-5f875a7ff804
DOI
10.21203/rs.3.rs-32276/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Risk Assessment and Management of Drug Inventory in Hospitals during COVID-19 Pandemic in TaiwanDOI 10.21203/rs.3.rs-32276/v1
Analysis and Solutions for Drug Shortages in Multi-level Medical Institutions in China: References for Developing CountriesSemantic proximity
What Ails Drug Supply Chains? A Model for Diagnosis and Suggestions for a CureSemantic proximity
Supply Chain Vulnerabilities in First-Line Treatments for Sexually Transmitted Infections: Implications for U.S. Public Health PreparednessSemantic proximity
When Do Drug Shortages Raise Acquisition Costs? Average Duration Effects and Heterogeneous Price Pass-ThroughSemantic proximity
Closing the Loop: An Integrative Framework for Managing Unwanted Pharmaceuticals During COVID-19 and BeyondSemantic proximity
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?Semantic proximity
The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national databaseSemantic proximity
Access to Essential and Innovative Anti-cancer Medicines: A Longitudinal Study in Nanjing, ChinaSemantic proximity
A Study on the Heterogeneous Effects of China’s Volume- Based Procurement on Gastrointestinal and Metabolic MedicationsSemantic proximity
Process integration models for emerging challenges: Optimal allocation of antivirals under resource constraintsSemantic proximity
Management of the Covid-19 Health Crisis: A Survey in Swiss Hospital PharmaciesSemantic proximity
Availability, Prices and Affordability of Nationally Negotiated Antidiabetic Drugs in China: A National SurveySemantic proximity
Select a neighboring publication to make it the new centre.